Position in MRK
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$3,970,007
+$398,237 QoQ
Shares Held
30,895
+4.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#388
of 1,644 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IFP Advisors, Inc holds $69,954,680 across 17 Drug Manufacturers - General names. MRK ranks #5 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
20,352 | $24,410,801 | |
| 2 | ABBV |
AbbVie Inc.
|
52,930 | $13,319,305 | |
| 3 | JNJ |
Johnson & Johnson
|
38,760 | $9,843,877 | |
| 4 | PFE |
Pfizer Inc
|
228,411 | $5,500,136 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
30,895 | $3,970,007 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
57,120 | $3,291,254 | |
| 7 | AMGN |
Amgen Inc
|
8,216 | $2,975,177 | |
| 8 | NVO |
Novo Nordisk A S
|
30,253 | $1,450,328 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,970,007 | 30,895 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $3,571,770 | 29,693 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $2,951,069 | 28,036 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,549,205 | 30,373 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $2,453,722 | 30,997 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $2,617,760 | 29,164 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $2,703,965 | 27,181 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $2,775,406 | 24,440 | Shares | Sole | 2025-02-04 | |
| 2024-06-30 | $2,591,010 | 20,929 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,930,824 | 14,633 | Shares | Sole | 2024-07-30 | |
| 2023-12-31 | $1,616,984 | 14,832 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $2,019,879 | 19,620 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $2,574,350 | 22,310 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,660,281 | 25,005 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $6,409,914 | 57,773 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $5,303,097 | 61,578 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $4,989,825 | 54,731 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $4,490,678 | 54,731 | Shares | Sole | 2022-09-06 | |
| 2021-12-31 | $2,248,387 | 29,337 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $2,258,407 | 30,068 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $1,943,938 | 24,996 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $1,445,746 | 18,754 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $1,500,620 | 18,345 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $1,623,415 | 19,571 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $1,398,204 | 18,081 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $1,351,142 | 17,561 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||